Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities
Identifieur interne : 004691 ( Main/Merge ); précédent : 004690; suivant : 004692Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities
Auteurs : Christophe Biot [France] ; Wassim Daher [France] ; Natascha Chavain [France] ; Thierry Fandeur [France] ; Jamal Khalife [France] ; Daniel Dive [France] ; Erik De Clercq [Belgique]Source :
- Journal of medicinal chemistry : (Print) [ 0022-2623 ] ; 2006.
Descripteurs français
- Pascal (Inist)
- Synthèse chimique, Antipaludique, Antiviral, Activité biologique, Quinoléine dérivé, Aminoalcool, Alcool primaire, Plasmodium falciparum, Coronavirus, In vitro, Antiparasitaire, Antiprotozoaire, Métallocène, Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl]), Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl]-N-éthyl), Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl]-N-méthyl), Ferrocène dérivé.
English descriptors
- KwdEn :
Abstract
Three ferroquine (FQ) derivatives, closely mimicking the antimalarial drug hydroxychloroquine (HCQ), have been prepared. Whereas these organometallic compounds provide the expected reduced cytotoxic effects compared to FQ, they inhibit in vitro growth of Plasmodium falciparum far better than chloroquine (CQ). Moreover, this new class of bioorganometallic compounds exert antiviral effects with some selectivity toward SARS-CoV infection. These new drugs may offer an interesting alternative for Asia where SARS originated and malaria has remained endemic.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000464
- to stream PascalFrancis, to step Curation: 000526
- to stream PascalFrancis, to step Checkpoint: 000490
Links to Exploration step
Pascal:06-0425480Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities</title>
<author><name sortKey="Biot, Christophe" sort="Biot, Christophe" uniqKey="Biot C" first="Christophe" last="Biot">Christophe Biot</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Catalyse et Chimie du Solide - UMR CNRS 8181, ENSCL, Bâtiment C7, USTL, B.P. 90108</s1>
<s2>59652, Villeneuve d' Ascq</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Villeneuve d' Ascq</wicri:noRegion>
<placeName><region type="region" nuts="2">Bourgogne-Franche-Comté</region>
<region type="old region" nuts="2">Franche-Comté</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Daher, Wassim" sort="Daher, Wassim" uniqKey="Daher W" first="Wassim" last="Daher">Wassim Daher</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chavain, Natascha" sort="Chavain, Natascha" uniqKey="Chavain N" first="Natascha" last="Chavain">Natascha Chavain</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Catalyse et Chimie du Solide - UMR CNRS 8181, ENSCL, Bâtiment C7, USTL, B.P. 90108</s1>
<s2>59652, Villeneuve d' Ascq</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Villeneuve d' Ascq</wicri:noRegion>
<placeName><region type="region" nuts="2">Bourgogne-Franche-Comté</region>
<region type="old region" nuts="2">Franche-Comté</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fandeur, Thierry" sort="Fandeur, Thierry" uniqKey="Fandeur T" first="Thierry" last="Fandeur">Thierry Fandeur</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>UMR Uniuersité-INRA d'lmmunologie Parasitaire, Faculté des Sciences Pharmaceutiques, 31, avenue Monge, Parc Grandmont</s1>
<s2>37200 Tours</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Centre-Val de Loire</region>
<region type="old region" nuts="2">Région Centre</region>
<settlement type="city">Tours</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Khalife, Jamal" sort="Khalife, Jamal" uniqKey="Khalife J" first="Jamal" last="Khalife">Jamal Khalife</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dive, Daniel" sort="Dive, Daniel" uniqKey="Dive D" first="Daniel" last="Dive">Daniel Dive</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Rega Institute for Medical Research, K.U.Leuven</s1>
<s2>3000 Leuven</s2>
<s3>BEL</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
<placeName><region type="province" nuts="2">Province du Brabant flamand</region>
<settlement type="city">Louvain</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0425480</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0425480 INIST</idno>
<idno type="RBID">Pascal:06-0425480</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000464</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000526</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000490</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000490</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Biot C:design:and:synthesis</idno>
<idno type="wicri:Area/Main/Merge">004691</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities</title>
<author><name sortKey="Biot, Christophe" sort="Biot, Christophe" uniqKey="Biot C" first="Christophe" last="Biot">Christophe Biot</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Catalyse et Chimie du Solide - UMR CNRS 8181, ENSCL, Bâtiment C7, USTL, B.P. 90108</s1>
<s2>59652, Villeneuve d' Ascq</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Villeneuve d' Ascq</wicri:noRegion>
<placeName><region type="region" nuts="2">Bourgogne-Franche-Comté</region>
<region type="old region" nuts="2">Franche-Comté</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Daher, Wassim" sort="Daher, Wassim" uniqKey="Daher W" first="Wassim" last="Daher">Wassim Daher</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chavain, Natascha" sort="Chavain, Natascha" uniqKey="Chavain N" first="Natascha" last="Chavain">Natascha Chavain</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Catalyse et Chimie du Solide - UMR CNRS 8181, ENSCL, Bâtiment C7, USTL, B.P. 90108</s1>
<s2>59652, Villeneuve d' Ascq</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Villeneuve d' Ascq</wicri:noRegion>
<placeName><region type="region" nuts="2">Bourgogne-Franche-Comté</region>
<region type="old region" nuts="2">Franche-Comté</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fandeur, Thierry" sort="Fandeur, Thierry" uniqKey="Fandeur T" first="Thierry" last="Fandeur">Thierry Fandeur</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>UMR Uniuersité-INRA d'lmmunologie Parasitaire, Faculté des Sciences Pharmaceutiques, 31, avenue Monge, Parc Grandmont</s1>
<s2>37200 Tours</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Centre-Val de Loire</region>
<region type="old region" nuts="2">Région Centre</region>
<settlement type="city">Tours</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Khalife, Jamal" sort="Khalife, Jamal" uniqKey="Khalife J" first="Jamal" last="Khalife">Jamal Khalife</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dive, Daniel" sort="Dive, Daniel" uniqKey="Dive D" first="Daniel" last="Dive">Daniel Dive</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Inserm, U547, Institut Pasteur, I rue du Pr Calmette, B.P. 245</s1>
<s2>59019 Lille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Lille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Rega Institute for Medical Research, K.U.Leuven</s1>
<s2>3000 Leuven</s2>
<s3>BEL</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
<placeName><region type="province" nuts="2">Province du Brabant flamand</region>
<settlement type="city">Louvain</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aminoalcohol</term>
<term>Antimalarial</term>
<term>Antiprotozoal agent</term>
<term>Antiviral</term>
<term>Biological activity</term>
<term>Chemical synthesis</term>
<term>Coronavirus</term>
<term>In vitro</term>
<term>Metallocene</term>
<term>Parasiticide</term>
<term>Plasmodium falciparum</term>
<term>Primary alcohol</term>
<term>Quinoline derivatives</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Synthèse chimique</term>
<term>Antipaludique</term>
<term>Antiviral</term>
<term>Activité biologique</term>
<term>Quinoléine dérivé</term>
<term>Aminoalcool</term>
<term>Alcool primaire</term>
<term>Plasmodium falciparum</term>
<term>Coronavirus</term>
<term>In vitro</term>
<term>Antiparasitaire</term>
<term>Antiprotozoaire</term>
<term>Métallocène</term>
<term>Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl])</term>
<term>Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl]-N-éthyl)</term>
<term>Ethanolamine(N-[(2-[([7-chloro-4-quinolyl]amino)méthyl]ferrocényl)méthyl]-N-méthyl)</term>
<term>Ferrocène dérivé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Three ferroquine (FQ) derivatives, closely mimicking the antimalarial drug hydroxychloroquine (HCQ), have been prepared. Whereas these organometallic compounds provide the expected reduced cytotoxic effects compared to FQ, they inhibit in vitro growth of Plasmodium falciparum far better than chloroquine (CQ). Moreover, this new class of bioorganometallic compounds exert antiviral effects with some selectivity toward SARS-CoV infection. These new drugs may offer an interesting alternative for Asia where SARS originated and malaria has remained endemic.</div>
</front>
</TEI>
<affiliations><list><country><li>Belgique</li>
<li>France</li>
</country>
<region><li>Bourgogne-Franche-Comté</li>
<li>Centre-Val de Loire</li>
<li>Franche-Comté</li>
<li>Hauts-de-France</li>
<li>Nord-Pas-de-Calais</li>
<li>Province du Brabant flamand</li>
<li>Région Centre</li>
</region>
<settlement><li>Lille</li>
<li>Louvain</li>
<li>Tours</li>
</settlement>
</list>
<tree><country name="France"><region name="Bourgogne-Franche-Comté"><name sortKey="Biot, Christophe" sort="Biot, Christophe" uniqKey="Biot C" first="Christophe" last="Biot">Christophe Biot</name>
</region>
<name sortKey="Chavain, Natascha" sort="Chavain, Natascha" uniqKey="Chavain N" first="Natascha" last="Chavain">Natascha Chavain</name>
<name sortKey="Daher, Wassim" sort="Daher, Wassim" uniqKey="Daher W" first="Wassim" last="Daher">Wassim Daher</name>
<name sortKey="Dive, Daniel" sort="Dive, Daniel" uniqKey="Dive D" first="Daniel" last="Dive">Daniel Dive</name>
<name sortKey="Fandeur, Thierry" sort="Fandeur, Thierry" uniqKey="Fandeur T" first="Thierry" last="Fandeur">Thierry Fandeur</name>
<name sortKey="Khalife, Jamal" sort="Khalife, Jamal" uniqKey="Khalife J" first="Jamal" last="Khalife">Jamal Khalife</name>
</country>
<country name="Belgique"><region name="Province du Brabant flamand"><name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004691 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004691 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Merge |type= RBID |clé= Pascal:06-0425480 |texte= Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities }}
This area was generated with Dilib version V0.6.33. |